CD44 and breast carcinoma: Furthermore, after undergoing standard chemotherapy treatment with docetaxel, doxorubicin, cyclophosphamide and trastuzumab, breast cancer cells that are CD44+ and CD24- were found to exhibit resistance to chemotherapy.